<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Press coverage &#8211; Aenitis Technologies</title>
	<atom:link href="https://www.aenitis.fr/category/press/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.aenitis.fr</link>
	<description>Reimagining bioprocessing with acoustic technology</description>
	<lastBuildDate>Mon, 01 Dec 2025 10:02:42 +0000</lastBuildDate>
	<language>fr-FR</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.aenitis.fr/wp-content/uploads/2025/11/cropped-favicon-aenitis-technologies-32x32.webp</url>
	<title>Press coverage &#8211; Aenitis Technologies</title>
	<link>https://www.aenitis.fr</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Aenitis has been featured in Les Echos</title>
		<link>https://www.aenitis.fr/aenitis-les-echos/</link>
		
		<dc:creator><![CDATA[Paul Saltet]]></dc:creator>
		<pubDate>Thu, 24 Oct 2024 18:45:00 +0000</pubDate>
				<category><![CDATA[Press coverage]]></category>
		<guid isPermaLink="false">https://mediumturquoise-lark-404744.hostingersite.com/?p=3025</guid>

					<description><![CDATA[We are delighted to announce that Aenitis has been featured in Les Echos following our successful fundraising to redefine bioproduction with our sole-in-class acoustofluidic technology!Thanks to Paul Molga for this enriching interview. Headline: «&#160;Aenitis raises 6.5 million euros for its cell sorting machines by levitation&#160;»Read the full article on Les Echos:&#160;https://www.lesechos.fr/pme-regions/innovateurs/aenitis-attire-65-millions-deuros-pour-ses-machines-de-tri-cellulaire-par-levitation-2124332 Together, we set to [&#8230;]
<p><a href="https://www.aenitis.fr/aenitis-les-echos/">Source</a></p>]]></description>
		
		
		
			</item>
		<item>
		<title>Aenitis has been featured in Biotech et Finances</title>
		<link>https://www.aenitis.fr/aenitis-biotech-finances/</link>
		
		<dc:creator><![CDATA[Paul Saltet]]></dc:creator>
		<pubDate>Thu, 24 Oct 2024 18:42:00 +0000</pubDate>
				<category><![CDATA[Press coverage]]></category>
		<guid isPermaLink="false">https://mediumturquoise-lark-404744.hostingersite.com/?p=3023</guid>

					<description><![CDATA[We are pleased to share that Aenitis has been featured in Biotech et Finances! Our CEO, Emmanuel Vincent, spoke with Guillaume Mollaret about our recent successful fundraising to redefine bioproduction with our unique acoustofluidic technology. During the discussion, Emmanuel Vincent also highlighted the addition of two new members to our Strategic Board and the significant [&#8230;]
<p><a href="https://www.aenitis.fr/aenitis-biotech-finances/">Source</a></p>]]></description>
		
		
		
			</item>
		<item>
		<title>Emmanuel Vincent: Fervently Driving Disruptive Innovation in Healthcare</title>
		<link>https://www.aenitis.fr/emmanuel-vincent-disruptive-innovation-in-healthcare/</link>
		
		<dc:creator><![CDATA[Paul Saltet]]></dc:creator>
		<pubDate>Thu, 24 Nov 2022 18:50:00 +0000</pubDate>
				<category><![CDATA[Press coverage]]></category>
		<guid isPermaLink="false">https://mediumturquoise-lark-404744.hostingersite.com/?p=3033</guid>

					<description><![CDATA[Success for some is the measure of wealth they have accumulated, while for some it is the respect they have earned. The word holds different meaning for different people. For&#160;Emmanuel Vincent, the&#160;Co-founder&#160;and&#160;CEO&#160;of&#160;Aenitis Technologies, it is the measure of how many lives he has saved or improved. Although, together we can move mountains but the strong [&#8230;]
<p><a href="https://www.aenitis.fr/emmanuel-vincent-disruptive-innovation-in-healthcare/">Source</a></p>]]></description>
		
		
		
			</item>
		<item>
		<title>Industrie Pharma : Aenitis à l’écoute pour optimiser la séparation</title>
		<link>https://www.aenitis.fr/industrie-pharma-aenitis/</link>
		
		<dc:creator><![CDATA[Paul Saltet]]></dc:creator>
		<pubDate>Sun, 24 Nov 2019 18:47:00 +0000</pubDate>
				<category><![CDATA[Press coverage]]></category>
		<guid isPermaLink="false">https://mediumturquoise-lark-404744.hostingersite.com/?p=3028</guid>

					<description><![CDATA[Une approche innovante pour optimiser les processus de bioproduction, via l’utilisation de la force acoustique, c’est ce que propose la start-up parisienne, hébergée au sein de l’hôpital Saint-Louis, Aenitis Technologies.&#160; Focus sur les quatre segments dans lesquels la jeune entreprise compte bien faire son chemin. Acoustophorèse ou lévitation acoustique, telle est le nom de la [&#8230;]
<p><a href="https://www.aenitis.fr/industrie-pharma-aenitis/">Source</a></p>]]></description>
		
		
		
			</item>
		<item>
		<title>La DGA s’allie à Aenitis Technologies en thérapie cellulaire</title>
		<link>https://www.aenitis.fr/dga-aenitis-technologies-therapie-cellulaire/</link>
		
		<dc:creator><![CDATA[Paul Saltet]]></dc:creator>
		<pubDate>Thu, 24 Oct 2019 18:49:00 +0000</pubDate>
				<category><![CDATA[Press coverage]]></category>
		<guid isPermaLink="false">https://mediumturquoise-lark-404744.hostingersite.com/?p=3031</guid>

					<description><![CDATA[Spin-off du CNRS et de l’ESPCI Paris, Aenitis Technologies développe des dispositifs médicaux de manipulation et de tri cellulaires basés sur l’utilisation de l’énergie acoustique. Ce mercredi, la société annonce la signature d’un partenariat avec la Direction générale de l’armement (DGA) pour mettre au point un nouveau processus de préparation des cellules stromales mésenchymateuses (CSM), [&#8230;]
<p><a href="https://www.aenitis.fr/dga-aenitis-technologies-therapie-cellulaire/">Source</a></p>]]></description>
		
		
		
			</item>
		<item>
		<title>Aenitis Technologies Receives €4M in Funding from the European H2020…</title>
		<link>https://www.aenitis.fr/aenitis-technologies-acoustic-blood-celle-sorter/</link>
		
		<dc:creator><![CDATA[Paul Saltet]]></dc:creator>
		<pubDate>Sun, 24 Dec 2017 18:52:00 +0000</pubDate>
				<category><![CDATA[Press coverage]]></category>
		<guid isPermaLink="false">https://mediumturquoise-lark-404744.hostingersite.com/?p=3035</guid>

					<description><![CDATA[“This funding will help to accelerate the roll-out of acoustic blood cell sorting technology to industrial scale”‍ Aenitis Technologies,&#160;which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare [&#8230;]
<p><a href="https://www.aenitis.fr/aenitis-technologies-acoustic-blood-celle-sorter/">Source</a></p>]]></description>
		
		
		
			</item>
	</channel>
</rss>
